• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(-)-表儿茶素对肿瘤坏死因子α诱导的Caco-2细胞屏障完整性丧失的预防作用

(-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.

作者信息

Contreras Telma C, Ricciardi Elisabetta, Cremonini Eleonora, Oteiza Patricia I

机构信息

Department of Nutrition, University of California, Davis, CA, USA; Department of Environmental Toxicology, University of California, Davis, CA, USA.

Department of Nutrition, University of California, Davis, CA, USA; Department of Environmental Toxicology, University of California, Davis, CA, USA.

出版信息

Arch Biochem Biophys. 2015 May 1;573:84-91. doi: 10.1016/j.abb.2015.01.024. Epub 2015 Mar 17.

DOI:10.1016/j.abb.2015.01.024
PMID:25795020
Abstract

An increased permeability of the intestinal barrier is proposed as a major event in the pathophysiology of inflammatory bowel diseases (IBD). Tumor necrosis alpha (TNFα) plays a central role in IBD pathogenesis, in part promoting tight function (TJ) barrier dysfunction. Food extracts enriched in (-)-epicatechin (EC) prevent the development or improve the progression of IBD in animal models. This study investigated the capacity of EC to inhibit TNFα-induced permeabilization of Caco-2 cell monolayers, characterizing the underlying mechanisms. Caco-2 cells differentiated into intestinal epithelial cells were incubated in the absence/presence of TNFα, with or without the addition of 0.5-5 μM EC. TNFα triggered cell monolayer permeabilization, decreasing transepithelial electrical resistance (TEER) and increasing the paracellular transport of fluorescein sulfonic acid. The permeabilizing effects of TNFα were not due to Caco-2 cell apoptosis as evaluated by DNA fragmentation, caspase 3 and 9 activation, and cell morphology. EC prevented TNFα-triggered Caco-2 monolayer permeabilization and acted inhibiting the associated: (i) NADPH oxidase (NOX)-mediated increased oxidant production, (ii) NF-κB (IκBα phosphorylation, p50 and RelA nuclear transport, and nuclear NF-κB-DNA binding) and ERK1/2 activation, (iii) increased myosin light kinase expression, and decreased TJ protein ZO-1 levels. In summary, EC prevented TNFα-mediated Caco-2 cell barrier permeabilization in part through the inhibition of NOX/NF-κB activation and downstream TJ disruption. Diets rich in EC could contribute to ameliorate IBD-associated increased intestinal permeability.

摘要

肠屏障通透性增加被认为是炎症性肠病(IBD)病理生理学中的一个主要事件。肿瘤坏死因子α(TNFα)在IBD发病机制中起核心作用,部分促进紧密连接(TJ)屏障功能障碍。富含(-)-表儿茶素(EC)的食物提取物可预防动物模型中IBD的发生或改善其进展。本研究调查了EC抑制TNFα诱导的Caco-2细胞单层通透性的能力,并对其潜在机制进行了表征。将分化为肠上皮细胞的Caco-2细胞在有无TNFα的情况下孵育,添加或不添加0.5-5μM EC。TNFα触发细胞单层通透性增加,降低跨上皮电阻(TEER)并增加荧光素磺酸的细胞旁运输。通过DNA片段化、caspase 3和9激活以及细胞形态评估,TNFα的通透作用并非由于Caco-2细胞凋亡。EC可防止TNFα触发的Caco-2单层通透性增加,并抑制相关的:(i)NADPH氧化酶(NOX)介导的氧化剂产生增加,(ii)NF-κB(IκBα磷酸化、p50和RelA核转运以及核NF-κB-DNA结合)和ERK1/2激活,(iii)肌球蛋白轻链激酶表达增加以及TJ蛋白ZO-1水平降低。总之,EC部分通过抑制NOX/NF-κB激活和下游TJ破坏来防止TNFα介导的Caco-2细胞屏障通透性增加。富含EC的饮食可能有助于改善IBD相关的肠道通透性增加。

相似文献

1
(-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.(-)-表儿茶素对肿瘤坏死因子α诱导的Caco-2细胞屏障完整性丧失的预防作用
Arch Biochem Biophys. 2015 May 1;573:84-91. doi: 10.1016/j.abb.2015.01.024. Epub 2015 Mar 17.
2
Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.阿达木单抗可防止屏障功能障碍,并拮抗 TNF-α 对肠道上皮细胞紧密连接蛋白和信号通路的不同作用。
Am J Physiol Gastrointest Liver Physiol. 2013 Jun 1;304(11):G970-9. doi: 10.1152/ajpgi.00183.2012. Epub 2013 Mar 28.
3
TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.肿瘤坏死因子-α诱导的肠上皮紧密连接通透性增加需要核因子-κB激活。
Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G367-76. doi: 10.1152/ajpgi.00173.2003.
4
Anthocyanins inhibit tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.花色苷抑制肿瘤坏死因子-α诱导的 Caco-2 细胞屏障完整性丧失。
Food Funct. 2017 Aug 1;8(8):2915-2923. doi: 10.1039/c7fo00625j. Epub 2017 Jul 25.
5
(-)-Epicatechin and NADPH oxidase inhibitors prevent bile acid-induced Caco-2 monolayer permeabilization through ERK1/2 modulation.(-)-表儿茶素和 NADPH 氧化酶抑制剂通过调节 ERK1/2 预防胆汁酸诱导的 Caco-2 单层通透性增加。
Redox Biol. 2020 Jan;28:101360. doi: 10.1016/j.redox.2019.101360. Epub 2019 Oct 22.
6
Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.谷氨酰胺和精氨酸可改善甲氨蝶呤处理的 Caco-2 细胞的通透性和紧密连接蛋白表达。
Clin Nutr. 2013 Oct;32(5):863-9. doi: 10.1016/j.clnu.2013.01.014. Epub 2013 Feb 1.
7
Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.肿瘤坏死因子-α调节肠上皮紧密连接屏障的分子机制
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G496-504. doi: 10.1152/ajpgi.00318.2005.
8
GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.在肠道屏障的Caco-2细胞模型中,胰高血糖素样肽-2(GLP-2)可增强屏障形成并减轻肿瘤坏死因子α(TNFα)诱导的变化。
Regul Pept. 2012 Oct 10;178(1-3):95-101. doi: 10.1016/j.regpep.2012.07.002. Epub 2012 Jul 15.
9
Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.大黄素通过抑制NF-κB和HIF-1α信号通路改善缺氧和脂多糖诱导的肠上皮屏障功能障碍。
Int J Mol Med. 2014 Dec;34(6):1629-39. doi: 10.3892/ijmm.2014.1965. Epub 2014 Oct 13.
10
Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.蛋白激酶C的ζ亚型可防止氧化剂诱导的核因子-κB激活和I-κBα降解:这是表皮生长因子保护微管细胞骨架和肠屏障完整性的基本机制。
J Pharmacol Exp Ther. 2003 Oct;307(1):53-66. doi: 10.1124/jpet.103.053835. Epub 2003 Jul 31.

引用本文的文献

1
Natural Products and Diabetes: (-)-Epicatechin and Mechanisms Involved in the Regulation of Insulin Sensitivity.天然产物与糖尿病:(-)-表儿茶素及胰岛素敏感性调节机制
Handb Exp Pharmacol. 2025;287:159-173. doi: 10.1007/164_2024_707.
2
The synergistic ramification of insoluble dietary fiber and associated non-extractable polyphenols on gut microbial population escorting alleviation of lifestyle diseases.不溶性膳食纤维与相关不可提取多酚对肠道微生物群的协同分支作用有助于缓解生活方式疾病。
Food Chem X. 2023 May 2;18:100697. doi: 10.1016/j.fochx.2023.100697. eCollection 2023 Jun 30.
3
Flavonoids in Crevost et Lemarie Ameliorate Loperamide-Induced Constipation in Mice by Regulating Gut Microbiota and Related Metabolites.
类黄酮可通过调节肠道微生物群及其相关代谢物改善洛哌丁胺诱导的小鼠便秘。
Int J Mol Sci. 2023 Apr 13;24(8):7191. doi: 10.3390/ijms24087191.
4
Anti-Inflammatory, Antioxidant Activities, and Phytochemical Characterization of Edible Plants Exerting Synergistic Effects in Human Gastric Epithelial Cells.可食用植物在人胃上皮细胞中发挥协同作用的抗炎、抗氧化活性及植物化学特征
Antioxidants (Basel). 2023 Feb 27;12(3):591. doi: 10.3390/antiox12030591.
5
Leaky Gut and the Ingredients That Help Treat It: A Review.肠漏症与有助于治疗它的成分:综述。
Molecules. 2023 Jan 7;28(2):619. doi: 10.3390/molecules28020619.
6
The Role of Catechins in Regulating Diabetes: An Update Review.儿茶素在调节糖尿病中的作用:更新综述。
Nutrients. 2022 Nov 4;14(21):4681. doi: 10.3390/nu14214681.
7
Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis.肠道阴离子交换器 SLC26A3 的小分子抑制剂用于治疗高草酸尿症和肾结石病。
JCI Insight. 2022 Jul 8;7(13):e153359. doi: 10.1172/jci.insight.153359.
8
Present and Future Therapeutic Approaches to Barrier Dysfunction.屏障功能障碍的当前及未来治疗方法
Front Nutr. 2021 Oct 28;8:718093. doi: 10.3389/fnut.2021.718093. eCollection 2021.
9
Antioxidant Therapy in Inflammatory Bowel Diseases.炎症性肠病中的抗氧化治疗
Antioxidants (Basel). 2021 Mar 9;10(3):412. doi: 10.3390/antiox10030412.
10
Protective Effect of Cocoa Bean Shell against Intestinal Damage: An Example of Byproduct Valorization.可可豆壳对肠道损伤的保护作用:副产品增值的一个实例
Antioxidants (Basel). 2021 Feb 12;10(2):280. doi: 10.3390/antiox10020280.